This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Metabolic Syndrome and Cardiovascular Risk
joint with Nuclear Receptor Pathways to Metabolic Regulation
Organizer(s): Bart Staels, Jean E. Schaffer and Juleen R. Zierath
Date: March 27 - April 01, 2007
Location: Sheraton Steamboat Resort, Steamboat Springs, CO, USA
Part of the Translational Medicine Series, Sponsored by Pfizer Global Research & Development
Summary of Meeting:
The metabolic syndrome is a complex entity of metabolic disorders clustering around acquired visceral obesity. These metabolic abnormalities include alterations in glucose homeostasis associated with insulin resistance, atherogenic dyslipidemia, coagulation disturbances and, in many cases, hypertension. Metabolic syndrome patients are at high risk to develop type 2 diabetes and most often die from cardiovascular diseases. Already identified in the early 1950’s and formally presented as syndrome X in the 1980’s, the metabolic syndrome is achieving epidemic proportions in the 21st century, due to global changes in life-style. In this meeting, the most recent conceptual advances in our understanding of the pathogenesis of the metabolic syndrome, its different metabolic components as well as its cardiovascular complications, will be discussed. This meeting aims to integrate approaches from basic and translational science, with an overall goal of understanding 1) how to translate this science into a more optimal lifestyle management and 2) the prospects for therapeutic intervention.
Scholarship Deadline: November 27 2006
Discounted Abstract Deadline: November 27 2006
Abstract Deadline: December 28 2006
Discounted Registration Deadline: January 29 2007
We gratefully acknowledge additional support for this conference from:
EMD MilliporePfizer Global Research & Development
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Merck Research Laboratories

Sanofi US
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1 R13 DK076500-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found